Alpha-Synuclein Oligomers-Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders
about
The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative DiseasesHolocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effectsProtein misfolding in neurodegenerative diseases: implications and strategies.DT-diaphorase Protects Against Autophagy Induced by Aminochrome-Dependent Alpha-Synuclein Oligomers.Rabs, Membrane Dynamics, and Parkinson's Disease.Resveratrol and Brain Mitochondria: a Review.Quantitative proteomics in A30P*A53T α-synuclein transgenic mice reveals upregulation of Sel1l.Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes.Recent advances in pharmacological research on Ecklonia species: a review.Alpha-synuclein oligomers: a new hope.Parkinson's Disease Is Not Simply a Prion Disorder.α-Synuclein Dimers Impair Vesicle Fission during Clathrin-Mediated Synaptic Vesicle Recycling.Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease.Taurine protects dopaminergic neurons in a mouse Parkinson's disease model through inhibition of microglial M1 polarization.Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson's Disease?Single-Molecule Characterization of the Interactions between Extracellular Chaperones and Toxic α-Synuclein Oligomers.Secretion and Uptake of α-Synuclein Via Extracellular Vesicles in Cultured CellsProteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson's disease modelImmunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammationCeftriaxone Treatment for Neuronal Deficits: A Histological and MEMRI Study in a Rat Model of Dementia with Lewy Bodies
P2860
Q33692255-E04DCB3E-9665-4459-8374-24AFBB5A1E03Q33734084-1344F551-C5E2-49C3-ABE0-1695ADE1213BQ37697832-06A7FCAB-AC3E-4B19-BB33-26694D088E23Q38704492-A82AAE46-A858-4C35-9A59-FC2334D1B9E6Q39031304-70B7ADCA-84C0-45C3-8420-6082F1E20CC2Q39173672-5EF453C6-B43D-400C-B54A-E10A29A8D17EQ41235948-C9CF8384-58FA-44A0-BCFC-41E55F019EE1Q46243605-20D5171B-A5E6-42CC-97A9-5C0C09130E56Q46316469-67883B08-8B01-47F9-892E-91177AD265F3Q46321755-69856C4A-832E-48A1-AF1F-14227FB81F35Q47314960-A182C679-FC47-4F5C-B1CA-1AC5673EBF06Q49330024-FE7FAC4D-B85F-4402-9A3D-755F8FE88A74Q52363911-E40F8DE8-D788-4979-A5BD-016F6A4C9AA7Q52641738-547F8198-62D3-45FA-AB96-C7D0CD3D3C3AQ54942358-6FCE1887-6E97-442B-8C89-B11FA52D7576Q55443026-5CEB852D-D081-4D63-8CAF-54084D1FAA6CQ57025391-E7C1BC47-37CA-4B54-A80D-E667A693B89FQ58722552-3BE7881A-2A7B-4365-9647-01D6A87F6890Q58793525-738C8DEF-7702-4BF8-90D8-0EE8F453AF81Q58805879-22D54249-D143-4C38-B697-B4901A18D12B
P2860
Alpha-Synuclein Oligomers-Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Alpha-Synuclein Oligomers-Neur ...... and Other Lewy Body Disorders
@ast
Alpha-Synuclein Oligomers-Neur ...... and Other Lewy Body Disorders
@en
Alpha-Synuclein Oligomers-Neur ...... and Other Lewy Body Disorders
@nl
type
label
Alpha-Synuclein Oligomers-Neur ...... and Other Lewy Body Disorders
@ast
Alpha-Synuclein Oligomers-Neur ...... and Other Lewy Body Disorders
@en
Alpha-Synuclein Oligomers-Neur ...... and Other Lewy Body Disorders
@nl
prefLabel
Alpha-Synuclein Oligomers-Neur ...... and Other Lewy Body Disorders
@ast
Alpha-Synuclein Oligomers-Neur ...... and Other Lewy Body Disorders
@en
Alpha-Synuclein Oligomers-Neur ...... and Other Lewy Body Disorders
@nl
P2860
P921
P3181
P356
P1476
Alpha-Synuclein Oligomers-Neur ...... and Other Lewy Body Disorders
@en
P2860
P3181
P356
10.3389/FNINS.2016.00408
P407
P577
2016-09-05T00:00:00Z